Processa Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (PCSA)

CUSIP: 74275C304

Q2 2024 13F Holders as of 30 Jun 2024

Holder snapshot 6 signals
Share change
-61,302
SEC-reported price per share
$2.24
Number of holders
8
Value change
-$146,754
Number of buys
1
Number of sells
6
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
2,857,143

Security key

74275C304

Report period

Q2 2024

Institutions

8

Top holders

8

Ownership snapshot

Top reported holders of PCSA - Processa Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
SABBY MANAGEMENT, LLC
Disclosed value leader
SABBY MANAGEMENT, LLC
Comparable rows
0/14
Latest evidence
05 Apr 2024
13F 3/4/5 Highest disclosed value: $114,941 14 rows are not safely comparable across share classes. Showing 1-6 of 14 holder rows.

Quick read

SABBY MANAGEMENT, LLC has the largest disclosed position value at $114.9K.

0 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens SABBY MANAGEMENT, LLC's linked filing trail.
Disclosed position value Top 5
SABBY MANAGEMENT, LLC $114.9K
James H. Stanker $61.6K
VANGUARD GROUP INC $57.8K
TWO SIGMA INVESTMENTS, LP $57K
Robert Michael Floyd $51.6K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 14 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
SABBY MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$114,941
48,601 shares
— 31 Mar 2024
James H. Stanker
3/4/5
Chief Financial Officer
—
mixed-class rows
$61,609
36,029 shares
mixed-class rows
— 05 Apr 2024
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$57,784
24,433 shares
— 31 Mar 2024
TWO SIGMA INVESTMENTS, LP
13F
Company
13F
—
denominator unverified
$56,987
24,096 shares
— 31 Mar 2024
Robert Michael Floyd
3/4/5
Chief Operating Officer
—
denominator unverified
$51,618
172,061 shares
— 09 Feb 2023
Virgil Thompson
3/4/5
Director
—
mixed-class rows
$42,163
241,907 shares
mixed-class rows
— 27 Jun 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
8
Shares
45,030
Rows available
8
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q3 2025 Across Filers

Q3 2025 holders
13
Q2 2024 holders
8
Holder diff
-5
Investor Q3 2025 Shares Q2 2024 Shares Share Diff Share Chg % Q3 2025 value Q2 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .